Fresenius Medical Care plans to sell select assets of Spectra Laboratories to Quest Diagnostics as it exits non-core markets.

The scale of Fresenius Medical Care’s transformation plan has become evident in a 2024 earnings release as it continues to ...

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, recently announced that it has been selected as one of the 2025 World's Most Admired Companies™ by Fortune® ...

Fresenius Medical Care announced today that it agreed to sell select assets of its laboratory testing services to Quest ...

DGX stays on investors' radars due to its robust prospects in Advanced Diagnostics and progress in the acquisition strategy.

The FDA has granted EUA to Aptitude Medical Systems’ Metrix Covid/Flu multiplex test for over-the-counter use.

Nick Slowik was rocked by stage 4 prostate cancer diagnosis. But after surgery, local high school basketball official returned to court.

The acquisition will add dialysis-related water testing to Quest’s portfolio and position the company to perform the tests ...